Dr. James P. Miller, a trauma surgeon and ICU provider at Providence Regional Medical Center in Everett, Washington, helped treat the first diagnosed COVID-19 patient in the United States in January 2020. He watched the federal government ship remdesivir to his hospital at $5,000 a bag. He watched nurses get sent home because there weren't enough patients to justify their shifts. And he watched the head of infectious disease at his own hospital quietly work with state officials to strip civil rights from people who refused the vaccine.
Now he's talking.
Miller testified on Capitol Hill, laying out what he called a pattern of fraud, deadly treatment protocols, and institutional retaliation against medical professionals who questioned the official narrative. His testimony lands as Sen. Ron Johnson (R-WI) continues to press the COVID accountability case through congressional roundtables and ahead of the upcoming MAHA summit.
The core of Miller's testimony is remdesivir — the drug the federal government pushed into hospitals nationwide while the evidence against it was already piling up. The World Health Organization recommended against its use in November 2020. By the time the numbers were tallied, 2,751 deaths had been linked to the drug over 69 months.
Miller didn't mince it. "Any physician honestly reviewing the real-world data at that time could have recognized early that remdesivir caused more harm than good," he testified.
The drug kept flowing anyway. At $5,000 per bag, supplied by Gilead and distributed through federal channels, hospitals had a financial incentive to administer it regardless of outcomes. Miller described a situation where a patient was given remdesivir even when a provider had reservations — noting that the administering individual "seemed like a nice girl" who was simply following the protocol she'd been handed.
That's the machinery. Individual providers weren't making independent medical judgments. They were executing a federal protocol backed by financial incentives, and the people who raised concerns about patient outcomes were treated as the problem.
Which brings us to the part of Miller's testimony that should keep people up at night. He stated plainly that Dr. George Diaz, the head of infectious disease medicine at Providence Regional Medical Center, "privately told me that he was working with the state government to restrict the civil rights of unvaccinated people."
The usual defense of COVID-era policy leans on the argument that officials were acting under unprecedented uncertainty with imperfect information. Miller's testimony guts that framing. The WHO had already flagged remdesivir by November 2020. The death data was accumulating in real time. Hospitals were sending nurses home for lack of patients while the messaging publicly inflated infection and death counts. The information wasn't imperfect. It was ignored.
Miller's account also fills in a piece of the puzzle that congressional investigators have been assembling for years. Sen. Ron Johnson's COVID roundtables have produced testimony from frontline doctors, vaccine-injured patients, and public health whistleblowers — each one adding a data point to the same picture. The pattern isn't isolated bad actors. It's a system that rewarded compliance, punished dissent, and insulated itself from accountability by labeling every critic a conspiracy theorist.
The Cleveland Clinic's own research has since raised questions about the protocols that were treated as gospel during the pandemic. But Miller isn't citing studies from a distance. He was in the building. He treated the first patient. He saw what happened when the federal response arrived, and he watched colleagues get retaliated against for saying what the data already showed.
The MAHA summit is approaching. Johnson's hearings continue. And a surgeon who was there from day one — literally the first hospital, the first patient — is now on the record.
Comments are closed.